Catalyst Wire Dossier Catalyst Wire Dossier

LHW090

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LHW090, covering 2018-07-05 to 2020-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function [Phase 2]

See pricing